Ask AI
ProCE Banner Activity

Answering the Questions on Rapid ART Initiation

Video

Hear from expert faculty as they discuss questions about rapid ART initiation for HIV including guideline recommendations, data to support improved clinical outcomes, and rapidly transitioning from PrEP to ART after HIV seroconversion.

Released: April 10, 2023

Continue Activity

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Determine whether and how to implement rapid ART in newly diagnosed people with HIV

Financial Disclosures

Primary Author

Isolde F. Butler, MD, MPH

Chief Medical Officer
Crescent Care
New Orleans, Louisiana 

Isolde F. Butler, MD, MPH, has no relevant financial relationships to disclose.

Contributing Author

Brenda Crabtree Ramírez, MD

Professor of the HIV Program, UNAM
Senior HIV Researcher at the Infectious Disease Department
Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran
Mexico City, Mexico

Brenda E. Crabtree Ramírez, MD, has no relevant financial relationships to disclose.

Format

The program has been made available online.